Sign in

CIK 0001420720

  • Non-accelerated filer
  • Smaller reporting company
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
262797813
Phone
+1 302-355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
  1. 4 Grant or award Chief Financial Officer acquired 37,500 shares (grant or award)
  2. 4 Open-market sale Brenner Martin sold 5,213 shares at $2.13 ($11,112)
  3. 4 Open-market sale Brenner Martin sold 3,976 shares at $1.77 ($7,038)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Interim CEO and CSO acquired 130,000 shares (grant or award)
  6. 4 Grant or award Chief Scientific Officer acquired 95,348 shares (grant or award)
  7. 4 Grant or award Lutz Robert Matthew acquired 100,057 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Lutz Robert Matthew sold 24,625 shares at $0.35 ($8,510)
  12. 4 Open-market sale Chief Operating Officer sold 37,243 shares at $0.68 ($25,444)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4/A Insider Changes in Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 13 · 260 filings